| SPI1 |
SPI1: Transcription factor PU.1 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
2.435 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
2.435 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
PDCD1 |
PDCD1, PD1: Programmed cell death protein 1 precursor |
2.435 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
2.435 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
2.435 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
2.435 |
Evidence |
|
| FGA |
IPI00021885 |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
2.435 |
Evidence |
|
| FGA |
IPI00021885 |
LILRA3 |
LILRA3, ILT6, LIR4: Leukocyte immunoglobulin-like receptor subfamily A member 3 |
2.435 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
2.435 |
Evidence |
|
| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
GRAP |
GRAP: GRB2-related adapter protein |
2.435 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
STIM2 |
STIM2, KIAA1482: Stromal interaction molecule 2 precursor |
2.435 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
STIM2 |
STIM2, KIAA1482: Stromal interaction molecule 2 precursor |
2.435 |
Evidence |
|
| PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
JAG1 |
JAG1, JAGL1: Jagged-1 precursor |
2.435 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
STIM2 |
STIM2, KIAA1482: Stromal interaction molecule 2 precursor |
2.435 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
2.435 |
Evidence |
|
| RGS20 |
RGS20, RGSZ1, ZGAP1: Regulator of G-protein signaling 20 |
OPRL1 |
OPRL1, OOR, ORL1: Nociceptin receptor |
2.435 |
Evidence |
|
| RGS20 |
RGS20, RGSZ1, ZGAP1: Regulator of G-protein signaling 20 |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
2.435 |
Evidence |
|
| RGS20 |
RGS20, RGSZ1, ZGAP1: Regulator of G-protein signaling 20 |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
2.435 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
2.435 |
Evidence |
|
| RGS12 |
RGS12: Regulator of G-protein signaling 12 |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
2.435 |
Evidence |
|
| DLL1 |
DLL1, UNQ146/PRO172: Delta-like protein 1 precursor |
PSEN2 |
PSEN2, AD4, PS2, PSNL2, STM2: Presenilin-2 |
2.435 |
Evidence |
|
| DLL1 |
DLL1, UNQ146/PRO172: Delta-like protein 1 precursor |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
2.435 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
2.43 |
Evidence |
|
| UNQ739 |
VWC2, UNQ739, hCG_2045125, tcag7.1302: von Willebrand factor C domain-containing |
LAMA3 |
|
2.43 |
Evidence |
|
| SHB |
SHB: SH2 domain-containing adapter protein B |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
2.43 |
Evidence |
|